---

---

tags : Cancer    symbols : Nvsef   

save search

---

Radiopharmaceuticals Market to Reach $11.6 Billion by 2034 as Cancer Treatment Gains Traction - Future Market Insights, Inc.
Published: 2024-03-25 (Crawled : 15:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -0.4% | O: -100.0% H: NaN% C: Infinity%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 2.73% | O: -0.08% H: 0.15% C: -0.44%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| -4.1% | O: 0.06% H: 0.96% C: 0.26%
CAH | $103.54 0.16% -0.52% 2.1M |

Distribution Services

| -7.7% | O: 0.02% H: 0.73% C: -0.02%
LNTH | $65.19 1.21% 1.2% 580K |

Health Technology

| 9.13% | O: 0.1% H: 1.98% C: -0.08%
reach cancer treatment market

---

Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -8.95% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -1.52% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 10.47% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -5.82% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $65.26 -4.38% 5.9K |

Manufacturing

| 28.21% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -14.66% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -9.46% | O: -0.2% H: 0.14% C: -0.48%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -3.61% | O: -0.06% H: 0.46% C: 0.29%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -1.67% | O: -0.69% H: 1.42% C: 1.22%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| -0.92% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -3.77% | O: -0.65% H: 1.63% C: 1.48%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| -3.85% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -0.15% | O: 1.67% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 8.85% | O: -2.81% H: 2.08% C: 1.38%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -3.5% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

---

9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published: 2024-02-19 (Crawled : 16:00) - prnewswire.com
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| Email alert Add to watchlist
VTRS | News A | $11.55 1.67% 1.65% 7.2M |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| Email alert Add to watchlist
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| Email alert Add to watchlist
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| Email alert Add to watchlist
JAZZ | $108.38 -1.18% -1.19% 400K |

Health Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| Email alert Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| Email alert Add to watchlist
cancer cell global growth market

---

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K |

Health Technology

| -14.57% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 4.83% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -6.68% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $65.26 -4.38% 5.9K |

Manufacturing

| 39.56% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -12.86% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -5.76% | O: 0.07% H: 0.42% C: 0.07%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -4.7% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -3.9% | O: 1.47% H: 0.0% C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 4.83% | O: 0.76% H: 4.31% C: 2.11%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -0.55% | O: -0.14% H: 0.35% C: -1.12%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| -0.87% | O: 1.48% H: 0.0% C: 0.0%
VRTX | $400.66 -1.05% -1.06% 810K |

Health Technology

| -2.7% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 1.14% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $108.38 -1.18% -1.19% 400K |

Health Technology

| -12.06% | O: -0.02% H: 0.0% C: -1.4%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 5.68% | O: -0.4% H: 0.19% C: -0.33%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -13.46% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

---

United States Endometrial Cancer Research Report 2023
Published: 2024-02-02 (Crawled : 10:00) - prnewswire.com
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -7.2% | O: 0.21% H: 0.49% C: -0.9%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -6.14% | O: -0.5% H: 0.26% C: -1.03%
report cancer research

---

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 1.27% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 6.9% | O: 3.41% H: 0.0% C: -2.45%
VTRS | News A | $11.55 1.67% 1.65% 7.2M |

Health Technology

| -3.81% | O: -0.08% H: 3.47% C: -0.25%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -8.25% | O: -2.04% H: 0.19% C: -1.97%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 5.5% | O: 4.04% H: 1.57% C: -3.02%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 2.8% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -6.39% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $4.84 -5.65% -5.99% 310K |

Health Technology

| 7.66% | O: -0.1% H: 2.31% C: -1.26%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 5.43% | O: 0.82% H: 0.12% C: -1.64%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -13.06% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

---

Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio
Published: 2024-01-09 (Crawled : 03:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K |

Health Technology

| -23.14% | O: 0.16% H: 0.0% C: -3.88%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -9.65% | O: -0.24% H: 0.0% C: 0.0%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -22.72% | O: -1.22% H: 0.0% C: -0.72%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -7.68% | O: -0.46% H: 0.74% C: -0.19%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -8.67% | O: 0.74% H: 0.0% C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -12.01% | O: -0.92% H: 0.63% C: -0.25%
america cancer treatment market

---

Cancer Immunotherapy Market to grow by USD 38.57 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio
Published: 2024-01-04 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 0.1% | O: 2.46% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -7.46% | O: 0.49% H: 0.6% C: -0.83%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 2.37% | O: 0.15% H: 1.88% C: -1.17%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -8.57% | O: -0.24% H: 1.43% C: 1.43%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -6.36% | O: 0.32% H: 0.93% C: 0.38%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 5.55% | O: -0.36% H: 0.98% C: 0.72%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -7.74% | O: -0.14% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 3.01% | O: -0.68% H: 0.87% C: 0.1%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -9.77% | O: -0.32% H: 0.44% C: 0.26%
america cancer immunotherapy market

---

Global Cancer Immunotherapy Market Poised to Exceed US$ 188 Billion by 2030, with CAGR of 10.02%
Published: 2023-12-14 (Crawled : 01:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -0.85% | O: -1.67% H: 1.17% C: 0.85%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -2.66% | O: 1.81% H: 0.0% C: 0.0%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -5.53% | O: 1.16% H: 0.14% C: -1.89%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -2.87% | O: -0.11% H: 0.5% C: -1.78%
cancer global immunotherapy market

---

US Kidney Cancer Therapeutics and Diagnostics Market to 2028, Featuring Profiles of Amgen, Hoffman-La Roche, Bayer, Pfizer, Bristol Myers Squibb and Novartis
Published: 2023-12-12 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 0.0% | O: 1.56% H: 0.51% C: 0.51%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 1.62% | O: 0.45% H: 0.75% C: 0.46%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 0.51% | O: 1.83% H: 0.04% C: -1.13%
kidney cancer novartis diagnostics therapeutics market

---

Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 10.33% | O: 1.64% H: 0.0% C: -1.33%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 11.57% | O: 1.51% H: 0.13% C: -1.68%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 1.95% | O: 0.52% H: 0.18% C: -0.43%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 13.52% | O: -0.03% H: 0.28% C: -0.41%
BAX | $40.93 -0.22% 0.0% 2.2M |

Health Technology

| 14.58% | O: 0.14% H: 0.78% C: 0.22%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 17.27% | O: 0.26% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 10.69% | O: 0.73% H: 0.06% C: -1.38%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 0.99% | O: 0.2% H: 0.2% C: -0.76%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M |

Technology Services

| 21.73% | O: 1.97% H: 0.0% C: 0.0%
GOOG | News 4 | $161.05 0.71% 0.7% 19M |

Technology Services

| 21.65% | O: 1.97% H: 0.0% C: 0.0%
ADBE A | $477.11 0.89% 0.88% 2M |

Technology Services

| -21.47% | O: 0.97% H: 0.08% C: -2.03%
tube companies abbvie cancer pharmaceuticals therapeutics market

---

Novartis Pluvicto™ shows clinically meaningful and highly statistically significant rPFS benefit in patients with PSMA-positive metastatic castration-resistant prostate cancer in the pre-taxane setting
Published: 2023-10-23 (Crawled : 14:30) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 4.41% | O: -0.17% H: 0.56% C: 0.18%
cancer novartis

---

Novartis Kisqali® NATALEE analysis reinforces consistent reduction in risk of recurrence across key subgroups of patients with early breast cancer
Published: 2023-10-20 (Crawled : 10:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M |

Health Technology

| -15.61% | O: -0.42% H: 0.16% C: -1.32%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 4.46% | O: 0.6% H: 0.61% C: -0.56%
kisqali breast cancer risk novartis

---

North America Leads the Global Peptide Drug Conjugates Market Due to Increased Cancer Incidence
Published: 2023-10-20 (Crawled : 01:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 4.46% | O: 0.6% H: 0.61% C: -0.56%
america drug cancer global market

---

Global Next Generation Cancer Diagnostics Market Research Report 2023-2030: Key Players are Focusing on Innovative Product Launches and Geographical Expansion to Maintain their Competitive Edge
Published: 2023-10-06 (Crawled : 09:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -0.93% | O: -0.72% H: 0.0% C: -0.52%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 2.82% | O: 0.95% H: 0.41% C: 0.08%
PHG | News | $20.97 -0.19% 0.0% 650K |

Health Technology

| 6.6% | O: -9.44% H: 2.86% C: 2.46%
A | $137.49 -1.23% -0.36% 1.6M |

Health Technology

| 24.83% | O: -1.81% H: 2.08% C: 1.05%
OPK | $1.225 -2.0% -2.04% 6.1M |

Health Technology

| -17.22% | O: -1.32% H: 2.68% C: 2.01%
MYGN | $18.61 0.05% 0.05% 480K |

Health Technology

| 20.08% | O: -0.97% H: 4.4% C: -0.59%
ILMN | $122.74 -1.38% -1.4% 1.2M |

Health Technology

| -10.74% | O: -1.36% H: 2.95% C: 1.8%
report cancer expansion research global diagnostics market

---

Novartis to present new oncology data at ESMO 2023 demonstrating practice-changing innovation in advanced prostate and early breast cancer
Published: 2023-10-05 (Crawled : 06:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 2.75% | O: -1.21% H: 1.3% C: 1.16%
breast innovation cancer novartis

---

Sandoz receives positive CHMP opinion for breast and gastric cancer biosimilar trastuzumab
Published: 2023-09-18 (Crawled : 06:00) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 12.39% | O: -0.05% H: 0.0% C: -1.31%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -3.67% | O: 0.06% H: 0.09% C: -0.6%
biosimilar chmp breast positive cancer

---

Global Next Generation Cancer Diagnostics Market Projected to Reach $57.8 Billion by 2030
Published: 2023-08-18 (Crawled : 00:20) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| Email alert Add to watchlist
reach cancer global diagnostics market

---

Prostate Cancer Global Market to Witness Upsurge in Growth at a CAGR of ~5% by 2028 | DelveInsight
Published: 2023-07-05 (Crawled : 21:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -33.6% | O: 0.86% H: 0.0% C: -1.01%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -0.09% | O: -1.17% H: 0.63% C: 0.22%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 58.7% | O: -0.55% H: 0.97% C: 0.02%
VERU | $1.325 3.92% 3.77% 1.5M |

Health Technology

| 5.83% | O: -0.83% H: 0.0% C: -6.72%
OPK | $1.225 -2.0% -2.04% 6.1M |

Health Technology

| -40.48% | O: -1.19% H: 1.2% C: -0.72%
ADXS | $0.54 12.48% 950 |

Health Technology

| -43.16% | O: 0.0% H: 0.0% C: -6.83%
cancer global growth market

---

Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published: 2023-06-27 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 7.57% | O: -1.1% H: 0.0% C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -15.38% | O: -0.95% H: 0.19% C: -0.32%
PFE | News 4 | $26.27 -0.19% -0.15% 23M |

Health Technology

| -28.65% | O: 0.19% H: 0.11% C: -1.46%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -0.65% | O: -0.01% H: 0.16% C: -0.32%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -8.54% | O: 0.03% H: 0.12% C: -0.24%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 13.7% | O: -0.91% H: 0.56% C: -0.5%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 63.23% | O: 2.15% H: 1.18% C: 0.43%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -24.39% | O: -0.06% H: 0.46% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| -1.23% | O: -0.21% H: 0.42% C: 0.13%
report business cancer treat global

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M |

Consumer Services

BOF | $1.99 70.09% 41.21% 110M |

ILAG | $0.51 6.03% 40.62% 1.7M |

LICN | $0.941 68.04% 40.49% 15M |

AMST | $3.31 65.5% 39.58% 70M |

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.45 12.5% 30.92% 320K |

Health Services

MULN | News | $3.78 38.46% 27.78% 13M |

Information

RILY | $29.86 37.48% 27.26% 12M |

Finance

---

Your saved searches

---